1 / 3

Medicines Patent Pool & Civil Society: Advancing Access & Flexibilities

The Medicines Patent Pool and Civil Society Delegations collaborate to ensure equitable access to medications, advocate for TRIPS flexibilities, include all countries, and address concerns. Progress milestones, budget agreements, and next steps are highlighted.

juan
Download Presentation

Medicines Patent Pool & Civil Society: Advancing Access & Flexibilities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Medicines Patent Pool and the Civil Society Delegations: Work to date... • Fought for establishment of Medicines Patent Pool (MPP) • Ensuring MPP does not damage existing mechanisms (TRIPS flexibilities) • Ensure inclusion of all Lower and Middle-Income countries (LICs/MICs) • 5-year MOU with UNITAID agreed • Get companies in negotiations December 2011 UNITAID Board meeting: • MPP met 1st year milestones. • 4-year budget and business plan agreed for remaining period of MOU Civil Society delegations raised concerns over: • Exclusion of Middle-Income Countries • Restrictions to place of production, sourcing of API (amongst others) Civil Society Delegations to UNITAID Board

  2. Next Steps: The Medicines Patent Pool (MPP) • Continue to use annual report against milestones to UNITAID Board to raise concerns of Civil Society • Listento broad Civil Society constituencies • Push originator companies to enter negotiations with MPP • Push companies and MPP for best possible licence agreements • Including all LICs and MICs, protect use of TRIPS flexibilities, oppose restrictions to place of production/sourcing of API • Voice concerns over new initiatives promoting bilateral licensing, without transparency e.g. HIV Medicines Alliance Civil Society Delegations to UNITAID Board

  3. Questions and Answers Civil Society Delegations to UNITAID Board

More Related